FOR THE ATTENTION OF:
Received this email directly
1) DHB Single Points of Contact
2) DHB Emergency Planners / Managers
3) Public Health Unit Managers
4) Medical Officers of Health
5) Chief Medical Officer
6) Director of Nursing
7) Relevant clinical and non-clinical staff in your DHB
8) GP Liaison Officers
9) Communications Managers
10) Any other deemed necessary by your organisation
This advisory has been sent separately to (DELETE/ADD AS APPROPRIATE Healthline, Plunketline, GPNZ, RNZCGP or others from the optional send list)
1. Forward internally within your organisation as per the 'attention of section' above
3. PHU Managers to please forward to Medical Officers of Health who may not be on the distribution list above.
4. Please forward to your primary care contacts including: general practitioners, pharmacists and primary health organisations in your region.
Thank you for the work you have been doing to combat the measles outbreak in New Zealand, all the while continuing to deliver high quality health services. Your work has certainly made a significant difference.
The current national priorities for MMR vaccination are:
There is no active recall for people outside of the priority groups at this time.
Given the outbreaks of measles in Samoa, Tonga, Philippines and Fiji, the Ministry of Health is asking primary care providers to ensure vaccinations are up-to-date for any individual (aged 50 and under) who indicates they will be travelling to one of these areas, or any country that has an active outbreak of measles. Outbreak regions can be found at https://wwwnc.cdc.gov/travel/notices/watch/measles-global.
We also recommend infants aged six to 11 months travelling to an outbreak area have one dose of MMR. Please remember that any child vaccinated before 12 months of age will still need two further doses of MMR.
All people need to be vaccinated at least two weeks before travel.
The Ministry will issue a public travel advisory on encouraging vaccination for people travelling to outbreak areas.
Addressing the immunity gap among 15 to 29 year-olds
New Zealand has a known immunisation gap for measles in the 15 to 29 age group. Planning is underway address this immunisation gap.
The Ministry of Health will begin contacting all DHBs about their plans for this 15 to 29 age group.
Please note: because planning is underway to improve immunity in this age group you do not need to actively recall people in this age group at the present time (unless your DHB has a regional plan, as part of its outbreak response).
Update on vaccine to meningococcal vaccine
From 1 December 2019, PHARMAC will be funding a meningococcal ACWY vaccine - Menactra) -for individuals aged 13 to 25 years in close-living situations.
This means that one dose of meningococcal ACWY vaccine is funded for those aged 13 years to 24 years (under 25 years) who:
In addition, from 1 December 2019 to 30 November 2020 people already living in boarding school hostels, tertiary education halls of residents, military barracks or prisons will also have access to the vaccine.
Providers will be able to enter the vaccinations given on the NIR via their PMS and claim for the vaccine administration in the same way they currently do for other special groups (high risk) vaccinations.
It is important to note that the ACWY vaccine does not provide protection against meningococcal B disease. As a result, it is important to consider meningococcal disease even in people who have been vaccinated if they present with symptoms consistent with meningococcal disease.
Changes to the National Immunisation Schedule
The Ministry of Health is currently working to finalise changes to the National Immunisation Schedule. We expect to be able to communicate finalised changes to the health sector early in the New Year.
If you have any queries about anything in this update, please email firstname.lastname@example.org